Tailored four-week online self-compassion program for adults with diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized controlled trial will randomize adults with Type 1 or Type 2 diabetes to a tailored four-week online Compassionate Mind Training course or to a waitlist control who receive the course later. Four self-report measures will be completed online at baseline (weeks 0–1) and after the intervention (weeks 9–10). The trial will focus on feasibility and acceptability metrics such as recruitment ease, participant retention in the intervention and study, completion of outcome measures, and acceptability ratings. Investigators will also look for a preliminary signal of efficacy on the primary outcome of diabetes distress to determine whether to progress to a full-scale RCT.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years old or older.
* Diagnosed with Type 1 or Type 2 diabetes by a clinician in the NHS more than one year ago.
* Self-managing theircondition.
* Identified by their NHS team as needing support with their mental health due to diabetes-related distress.

Exclusion Criteria:

* \<18
* Individuals experiencing a current mental health crisis, including severe depression, active suicidal thoughts, or acute psychosis
* Unable to read/speak English
* Gestational diabetes, Wolfram, and other rarer conditions
* Individuals currently experiencing severe substance abuse issues that could interfere with participation in the programme
* Individuals without reliable access to the internet and a compatible device (computer or smartphone).

Where it's running

• Betsi Cadwaladr University Health Board (BCUHB)
  Bangor, Wales, United Kingdom Recruiting
• Barts Health NHS Trust
  London, United Kingdom Not yet recruiting

Study contacts

• Principal investigator: Jodie Slevin, BSc — Canterbury Christ Church University
• Study coordinator: Jodie Slevin, BSc
• Email: js1624@canterbury.ac.uk
• Phone: +4407539333552

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tropocells autologous platelet-rich fibrin for healing mild-to-moderate neuroischemic diabetic foot ulcers

  This will test whether Tropocells autologous platelet-rich fibrin (PRF) helps close mild-to-moderate neuroischemic diabetic foot ulcers in adults with type 1 or type 2 diabetes.

  Recruiting at 2 sites Phase 2 Estar Medical dba Medical Technologies, LTD · Corpus Christi, Texas and 1 other locations · NCT06810726

• Lifestyle change program to help type 2 diabetes go into remission in Pakistan

  This study tests whether a structured, plant-predominant lifestyle program can put adults with type 2 diabetes in Lahore, Pakistan into remission for the first six months.

  Recruiting at 2 sites Green International University · Lahore, Punjab Province and 1 other locations · NCT07912944

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• VV-14300: a gene therapy approach for adults with type 1 diabetes not well controlled on an automated insulin system

  This trial tests VV-14300 in adults with type 1 diabetes who aren’t reaching their blood sugar goals despite using an automated insulin delivery system.

  Recruiting Phase 1/2 Kriya Therapeutics, Inc. · Toronto and 1 other locations · NCT07831798

• New gene therapies VV-14299 and VV-14300 for adults with Type 1 Diabetes failing automated insulin delivery

  This study tests VV-14299 and VV-14300, or VV-14300 alone, in adults with long-standing Type 1 Diabetes whose blood sugar remains poorly controlled despite using an automated insulin delivery system.

  Recruiting Phase 1/2 Kriya Therapeutics, Inc. · Melbourne · NCT07829302

• Oral verapamil in newly diagnosed children and teens with type 1 diabetes

  This study tests whether taking verapamil by mouth can help preserve pancreatic beta cells and reduce insulin needs in kids and teens with recently diagnosed type 1 diabetes.

  Recruiting Phase 2/3 Ain Shams University · Cairo · NCT07804849

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.